Trial intelligence / Profile preview

Bromfenac in femtosecond laser-assisted cataract surgery

ChiCTR-TRC-14005104Phase 4Recruiting

Sponsor
The Fourth Hospital of China Medical University
Start
Aug 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of bromfenac sodium in cataract (3 arms), sponsored by The Fourth Hospital of China Medical University. Primary endpoint: Aqueous prostaglandin E2 level. Started Aug 2014; status: recruiting.

02

Drugs

bromfenac sodium
03

Conditions

cataract

Beyond the preview

Go deeper on ChiCTR-TRC-14005104.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-14005104.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call